• 1
    Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009; 11: 229.
  • 2
    Bowman SJ, St Pierre Y, Sutcliffe N, Isenberg DA, Goldblatt F, Price E, et al. Estimating indirect costs in primary Sjögren's syndrome. J Rheumatol 2010; 37: 10105.
  • 3
    Westhoff G, Dorner T, Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study. Rheumatology (Oxford) 2012; 51: 2629.
  • 4
    Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, et al. Health-related quality of life, employment and disability in patients with Sjögren's syndrome. Rheumatology (Oxford) 2009; 48: 107782.
  • 5
    Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, et al. Primary Sjögren's syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 2009; 7: 46.
  • 6
    Elliott C, Frith J, Pairman J, Jones DE, Newton JL. Reduction in functional ability is significant postliver transplantation compared with matched liver disease and community dwelling controls. Transpl Int 2011; 24: 58895.
  • 7
    Newton JL, Elliott C, Frith J, Ghazala C, Pairman J, Jones DE. Functional capacity is significantly impaired in primary biliary cirrhosis and is related to orthostatic symptoms. Eur J Gastroenterol Hepatol 2011; 23: 56672.
  • 8
    Costigan A, Elliott C, McDonald C, Newton JL. Orthostatic symptoms predict functional capacity in chronic fatigue syndrome: implications for management. QJM 2010; 103: 58995.
  • 9
    Ng WF, Bowman SJ. Primary Sjögren's syndrome: too dry and too tired. Rheumatology (Oxford) 2010; 49: 84453.
  • 10
    Cai FZ, Lester S, Lu T, Keen H, Boundy K, Proudman SM, et al. Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study. Arthritis Res Ther 2008; 10: R31.
  • 11
    Mandl T, Hammar O, Theander E, Wollmer P, Ohlsson B. Autonomic nervous dysfunction development in patients with primary Sjögren's syndrome: a follow-up study. Rheumatology (Oxford) 2010; 49: 11016.
  • 12
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 5548.
  • 13
    Fries JF, Bruce B, Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol 2005; Suppl 39: S537.
  • 14
    Ng WF, Bowman SJ, Griffiths B. United Kingdom Primary Sjögren's Syndrome Registry: a united effort to tackle an orphan rheumatic disease. Rheumatology (Oxford) 2011; 50: 329.
  • 15
    Fries JF, Cella D, Rose M, Krishnan E, Bruce B. Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol 2009; 36: 20616.
  • 16
    Newton JL, Frith J, Powell D, Hackett K, Wilton K, Bowman S, et al. Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome. Ann Rheum Dis 2012. E-pub ahead of print.